Company Overview

An academic CRO, built where research happens.

ACRO Inc. (Academic Contract Research Organization) is a hospital-contracted CRO that supports the clinical research of university hospitals. Working alongside hospital clinical trial centers, ACRO places dedicated research teams where patients, investigators, and clinical data come together — combining academic rigor with hands-on clinical research execution.

Its work rests on four core competencies. Medical Affairs covers project planning, consulting, and medical writing; Biostatistics covers statistical analysis and real-world evidence generation; Digital Data Flow (DDF) covers data standardization, data management, and digital transformation; and Regulatory Science covers regulatory strategy, health technology assessment, and reimbursement.

Today ACRO works on a consulting-centered model across government research projects, investigator-initiated research, real-world evidence generation, and early-phase trials. Its direction is to grow — through industry–academia–hospital collaboration and digital-transformation-driven research efficiency — into an end-to-end partner across the full drug development lifecycle, from non-clinical through clinical to post-marketing.

Our History

How ACRO took shape

From incorporation to a hospital-embedded research operation — the first half of 2026, milestone by milestone.

— January 2026

ACRO Inc. established

Founded as an Academic Contract Research Organization to bridge Korean hospitals and global bioscience clusters — combining academic rigor with practical clinical research expertise.

— February 2026

Corporate Research Institute established (government-accredited)

Government-accredited corporate research institute registered with the national industrial technology association — formalizing ACRO's methodological and research capability as a standing research function.

— March 2026

In residence at Chonnam National University Hwasun Hospital

ACRO's research and biostatistics team co-located within the clinical trial center of a tertiary university hospital — placing the company where patients, investigators, and clinical data come together.

— April 2026

Government-commissioned research project awarded

Selected to carry out a government-commissioned research project for a national public-health research institute — ACRO's first publicly funded research engagement.

— May 2026

Registered as a specialized research-service provider

Formally registered as a specialized research-service provider under the Research Industry Promotion Act — recognizing ACRO's standing to deliver contract research and methodological services.

— June 2026

First paper published in JMIR (IF 6)

ACRO's first peer-reviewed paper accepted in the Journal of Medical Internet Research (JMIR) — a leading digital-health journal with an impact factor of 6 — marking the company's transition from setup to high-impact evidence generation.

— June 2026

MOU with Seoul National University Hospital Clinical Trials Center

Signed a memorandum of understanding with the Clinical Trials Center of Seoul National University Hospital — establishing a collaborative framework for clinical research and biostatistics support.

Vision · Mission · Core Values

Built on integrity, passion, and collaboration — bridging Korean research and the global bioscience ecosystem.

— Our Mission

Connecting the global research ecosystem.

ACRO works as a bridge between Korean hospitals and global bioscience clusters. Through networks with the world's leading bio hubs, we help Korean researchers contribute on the international stage — strengthening Korea's access to global innovation, clinical capability, and new research opportunities.

— Our Vision

Turning your hypothesis into success.

From a researcher's idea to academic and commercial success, ACRO accompanies every step. From preclinical data through publication and commercialization, we combine academic rigor with practical expertise to maximize the probability of research success — not an outsourcing vendor, but a strategic partner designing success alongside you.

— Our Approach

Academic rigor, practical expertise.

Sponsors get peer-reviewable evidence. Investigators get methodological partnership. Hospitals and academic societies get research infrastructure and statistical depth they can rely on — held together by CDISC standards and a single methodological backbone.

— 01
Integrity

Highest standards of research ethics and methodological transparency. Pre-specified analyses, honest reporting, documentation that would withstand audit.

— 02
Passion

Genuine investment in our clients' research outcomes — the curiosity and care of an academic partner, applied with the discipline of an industry team.

— 03
Trust

Long-term partnerships built on consistent delivery, methodological honesty, and the kind of reliability that earns repeat engagement.

— 04
Collaboration

Hospitals, academic societies, sponsors, and investigators all working on the same evidence backbone — methodology that crosses institutional lines.

Collaborations

Where we collaborate.

ACRO works alongside leading university hospitals — bringing biostatistics and clinical research methodology to where patients, investigators, and real-world data come together.

Seoul National University Hospital
Seoul National University HospitalSeoul · Clinical Trials Center MOU
Chonnam National University Hwasun Hospital
Chonnam National University Hwasun HospitalHwasun · In-residence